Bigul

PARNAX LAB LTD. - 506128 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Dear Sir, Pursuant to the provisions of Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulation, 2018, Please find enclosed herewith Compliance Certificate received from the Link Intime India Private Limited, Registrar and Share Transfer Agent (RTA) of our Company for the quarter ended 31st December, 2020. You are requested to take the same on record.
06-01-2021
Bigul

PARNAX LAB LTD. - 506128 - Statement Of Investor Complaints For The Quarter Ended December 2020

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Namrata KambliDesignation :- Company Secretary and Compliance Officer
05-01-2021
Bigul

PARNAX LAB LTD. - 506128 - Closure of Trading Window

Dear Sir/Madam, Pursuant to BSE Circulars dated 2nd April, 2019 vide Ref No: LIST/COMP/01/2019-20 please note that the Trading Window for dealing in the securities of the Company will remain closed for all Designated Persons with effect from 01st January, 2021 for the purpose of consideration of Unaudited Financial result for the quarter ended 31st December, 2020. The Trading Window shall open 48 hours after the Unaudited Financial Result for the quarter ended 31st December, 2020, become generally available to the Public. The above is for your information and record. Kindly take the same on your record and oblige.
31-12-2020
Bigul

PARNAX LAB LTD. - 506128 - Results-- Financial Results For Quarter And Half Year Ended 30.09.2020

Kindly find enclosed herewith the following: 1. A Copy of Standalone & Consolidated Un-Audited Financial results with Limited Review Report of the Company for the quarter and half year ended 30th September, 2020; Kindly take on record and acknowledge receipt of the same.
12-11-2020
Bigul

PARNAX LAB LTD. - 506128 - Outcome Of Board Meeting

Dear Sir, Pursuant to the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) we wish to inform you that in the meeting of the Board of Directors of the Company held on Thursday,12th November 2020 at its Registered Office, the Board inter alia has transacted the following business: 1. Approval of Un-Audited Standalone & Consolidated Financial Results as submitted by statutory auditor of the Company for the quarter and half year ended 30th September, 2020. 2. Considered and took note of Limited Review Report for the quarter and half year ended September 30, 2020. The Meeting was commenced at 4.00 p.m. and concluded at 7.00 p.m. Kindly take the same on your record. Thanking You,
12-11-2020
Bigul

PARNAX LAB LTD. - 506128 - Board Meeting Intimation for Approval Of Un-Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended 30Th September, 2020.

PARNAX LAB LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2020 ,inter alia, to consider and approve standalone and Consolidated Un-audited IND- AS Compliant Financial Results along with Limited Review Report for the quarter and half year ended 30th September 2020 pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement, 2015. 2. Any other business with permission of chair and with the consent of a majority of the Directors present in the Meeting including include at least one Independent Director. The approved results will be sent to you after conclusion of Board meeting. Kindly acknowledge the receipt of the same
03-11-2020
Bigul

PARNAX LAB LTD. - 506128 - Shareholding for the Period Ended September 30, 2020

Parnax Lab Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here
16-10-2020
Bigul

PARNAX LAB LTD. - 506128 - COMPLIANCE-Compliance As Per Regulation 40 (9) Of Listing Obligations And Disclosure Requirement Regulations 2015.

Dear Sir, Please find enclosed herewith the Compliance Certificate Pursuant Regulation 40 (9) of Listing Obligations and Disclosure Requirement Regulations 2015 for the half year ended 30th September, 2020. Kindly take the same on your record and acknowledge the receipt of the same. Thanking you, Yours truly,
15-10-2020
Bigul

PARNAX LAB LTD. - 506128 - Compliance- Compliance Certificate For The Half Year Ended 30Th September,2020.

Dear Sir/Madam, Please find enclosed herewith the certificate as per Regulation 7(3) of the Listing Obligations for the half year ended 30th September, 2020. Kindly take the same on your record.
14-10-2020
Bigul

PARNAX LAB LTD. - 506128 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Dear Sir, In reference to the above captioned regulation we have received confirmation from our Registrar & Transfer Agents Link Intime India Pvt. Ltd., that since there were no dematerialization requests during the quarter ended 30th September, 2020, therefore the Confirmation certificate as per Regulation 74 (5) is not applicable to the Company. This is for your information and records.
08-10-2020
Next Page
Close

Let's Open Free Demat Account